Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 10, 2006

View Archived Issues

Mechanism of cystatin C and E-64 action on osteoclast differentiation elucidated

Phase IIb adrenomyeloneuropathy study of RPI-78M cleared to begin

Agreement for animal study of human fibroblast growth factor-1 in osteoporosis

Alkermes licenses novel opioid receptor compounds discovered at Rensselaer

Gabapentin GR study in diabetic peripheral neuropathy completes enrollment

Influenza protecting virus developed at U. of Warwick

Grant to study two new drug classes in HIV-related nerve damage

Targanta updates preclinical studies of their lead antibiotic candidate oritavancin

Brivaracetam to enter clinical trials as an add-on therapy for Unverricht-Lundborg disease

U.K. approval for phase III cystic fibrosis study of Bronchitol to begin

Genentech files IND for Hedgehog antagonist from Curis collaboration

Novo Nordisk reveals plans for new clinical trials into 2007

SPA completed for Genasense plus chemotherapy in CLL

FX-06 studied in new phase II trial for reperfusion injury

Approvable letter for NRP-104 in ADHD

Myodur IND for Duchenne muscular dystrophy remains on hold

Pharming receives orphan product grant for Rhucin

Symbicort SMART completes European mutual recognition procedure

Ceplene filed for European approval in AML

Recent patents report novel treatment strategies for respiratory disorders

Tykerb filed for European approval in advanced breast cancer

Remicade approved in E.U. for second-line therapy for Crohn's disease

Recent patents report new treatments for depression, psychosis, sleep disorders, etc.

HIV reverse transcriptase inhibitors emerge from Roche R&D

R&D highlights from the UBS Global Life Sciences Conference in New York: Metabolic Pharmaceuticals

Novel antmicrobial biomimetic compounds developed at PolyMedix show efficacy in vivo

Taisho's new ketolide shows promising in vitro and in vivo activity

Paratek and Merck & Co.'s MK-2764 preclinical activity profiled at the ICAAC meeting

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...